{"ticker": {"uuid": "fab1bd99-595b-493a-ba47-bfcff1c519e0", "symbol": "DTIL", "name": "Precision BioSciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Trading the Move, Not the Narrative: (DTIL) Edition", "summary": "This article analyzes Precision Biosciences Inc. (NASDAQ: DTIL), highlighting weak near-term sentiment with a mid-channel oscillation pattern. It identifies an exceptional 62.0:1 risk-reward short setup and provides institutional trading strategies for different risk profiles. Th", "url": "https://news.stocktradersdaily.com/news_release/14/Trading_the_Move,_Not_the_Narrative:_DTIL_Edition_071526073401_1784115241.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-15T07:34:00", "published_display": "15 Jul 2026 07:34", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Precision BioSciences (DTIL) Proxy filing Summary", "summary": "Precision BioSciences (DTIL) will hold its annual meeting virtually on May 21, 2026, where shareholders will vote on critical proposals including the election of two Class I directors, auditor ratification, executive compensation, amendments to the 2019 Incentive Award Plan, offi", "url": "https://quartr.com/events/precision-biosciences-dtil-proxy-filing_FPmvy8rw", "source_name": "Quartr", "published_at": "2026-07-13T03:41:16", "published_display": "13 Jul 2026 03:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Short Interest & Short Float | Updated Jul 2026 $DTIL", "summary": "As of June 30, 2026, Precision BioSciences (DTIL) had 2.30 million shares sold short, representing 9.15% of its public float, marking an 18.16% increase from the prior report. The short interest ratio is 3.5 days to cover, indicating a generally positive sentiment. The article pr", "url": "https://www.marketbeat.com/stocks/NASDAQ/DTIL/short-interest/", "source_name": "MarketBeat", "published_at": "2026-07-11T03:33:44", "published_display": "11 Jul 2026 03:33", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Grants Stock Units to New Employees Amid G", "summary": "Precision BioSciences (DTIL) has granted 114,622 restricted stock units to three new employees to attract and retain talent in the competitive biotechnology sector. The company's stock is significantly overvalued according to GuruFocus's GF Value\u2122 of $1.83 compared to its current", "url": "https://www.gurufocus.com/news/8953513/precision-biosciences-grants-stock-units-to-new-employees-amid-growth?mobile=true%3Fmobile%3Dtrue", "source_name": "GuruFocus", "published_at": "2026-07-10T16:39:03", "published_display": "10 Jul 2026 16:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Grants Stock Units to New Employees Amid Growth", "summary": "Precision BioSciences (DTIL) recently granted 114,622 restricted stock units to three new employees as an incentive to attract and retain talent in the competitive biotechnology sector. While this move aims to align employee and shareholder interests, GuruFocus suggests the stock", "url": "https://www.gurufocus.com/news/8953513/precision-biosciences-grants-stock-units-to-new-employees-amid-growth", "source_name": "GuruFocus", "published_at": "2026-07-10T14:06:51", "published_display": "10 Jul 2026 14:06", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Grants Inducement Awards to New Hir", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdjEtdFdRRXhLTXFoWHpCSFdMc0pFQ3BhN1F4SzZPVUhRZnNKX09EbjBKV3dUcVQwaklLekg2dl9ja2VvYklJYkF4VXk0bzRhRmZtNlJPOWZyMkQ1SE1qZmlvSDlTYUR6NVRPejloOS1xQk4xRHd5aVQ3NFhxRHVLWEswRjNWVVVGbnItQzZ0ME1DQmZRYnRNSU9jSkpjQTRFS0d6LXNR?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T11:35:14+00:00", "published_display": "10 Jul 2026 11:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - July 10, 2026", "summary": "Precision BioSciences, Inc. announced the grant of inducement awards consisting of 114,622 restricted stock units (RSUs) to three new employees. These awards were approved by the Compensation Committee and granted under Nasdaq Listing Rule 5635(c)(4) to incentivize their employme", "url": "https://www.biospace.com/press-releases/precision-biosciences-announces-grant-of-inducement-awards-under-nasdaq-listing-rule-5635c4-july-10-2026", "source_name": "BioSpace", "published_at": "2026-07-10T12:10:51", "published_display": "10 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNdDlmSGRZQUZwTWxrVkJUd20yS2F3NjE3UHFLV1dLRk8tc0doSk9QeWxIUHdBYjFFX09zNFBlNmp1UHNGNTRfQkdIcHM1MTFrTGoxc2pmNG0zVUdnc1dMc3RkRmJ2NWZYdGtyODFTU1Q0cG03cEtHWjhBQWx1UzFPTU94RjVZaG1ZRlB1OUdKb3RZTEMtUTdXdGRoSk9ZeE1kYlVpejRwbk95WFBVR3g4ZmxlOGdGVm55VXBFazJYRnN6VEl5QTRVY3EtOWNOOV9hNTZCcWZzcF9Wekt0WlJyY3lR?oc=5", "source_name": "Business Wire", "published_at": "2026-07-10T11:01:00+00:00", "published_display": "10 Jul 2026 11:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New hires at Precision BioSciences receive 114,622 restricted stock units", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNcVZhYS1PekZPSEtOXzlmeDlTZFh6WklrTGhLSDNtbDRtQkx1N3l1OFR5NnJaZmNuNTNvbno4OEFRaUZUbk9RcEhISjhpaWRiTDJ5bzVJODd2NzRUdWZvOE00cFIzUHJvNkZLaC1MQTFONm9qYWlzcXRoLTBNcDU4UW5CRm5hVjhOY1Y2ek16YnZ6WUo4VTVxRC1mQXd5S3FwYkxEUXBoT2tkbXg1V2djUW40dzFfRVhpLUQyYQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T11:01:00+00:00", "published_display": "10 Jul 2026 11:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Grants Inducement Awards to New Hires", "summary": "Precision BioSciences (DTIL) has granted inducement awards, totaling 114,622 restricted stock units, to three new employees to attract and retain talent in the competitive biotechnology sector. Despite this strategic move, the company faces challenges including a declining revenu", "url": "https://www.gurufocus.com/news/8953278/precision-biosciences-dtil-grants-inducement-awards-to-new-hires", "source_name": "GuruFocus", "published_at": "2026-07-10T11:10:51", "published_display": "10 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $60", "summary": "H.C. Wainwright has reiterated its Buy rating for Precision BioSciences (DTIL.US) and maintained a target price of $60. This reflects the firm's continued positive outlook on the company's prospects.", "url": "https://www.moomoo.com/news/post/72710793/hc-wainwright-maintains-precision-biosciences-dtilus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-10T03:10:39", "published_display": "10 Jul 2026 03:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc. Actuals & Estimates (TRADEGATE:PBS0)", "summary": "This article provides financial actuals and estimates for Precision BioSciences, Inc. (PBS0) traded on the TRADEGATE exchange. It covers analyst forecasts, historical stock prices, upcoming earnings dates, and recent financial performance including earnings per share, revenue, an", "url": "https://www.tradingview.com/symbols/TRADEGATE-PBS0/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-07-10T00:10:51", "published_display": "10 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQTDUtdnREV2FLd2pUZGFJWVBsT1FoLXVUZmFuMHA2OFJESTUyRGtpVEpVd0ZDbGUxVzlWaVhjTUpZMUxpeVJ5Ql9XUS1iTHZPWEl0bDZDMUlWMWhnWlZIdDJUQ2ZULUNQZ24xVHVPQVRRdXNiRFFkU2dRLXV1ZUxHc293VjZfbS1Kc2dGVGlGbmdtUjVRSUFWWTRlV285M2ZYV3BrUlVKM2Y?oc=5", "source_name": "Market source", "published_at": "2026-07-08T14:32:00+00:00", "published_display": "08 Jul 2026 14:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Precision BioSciences, Inc. \u2013 NASDAQ:DTIL", "summary": "This article displays financial information for Precision BioSciences, Inc. (NASDAQ: DTIL) regarding its enterprise value to revenue forward. The content is presented within the TradingView platform, noting that the market is closed and no trades have occurred for the stock.", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T12:39:34", "published_display": "06 Jul 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Precision BioSciences, Inc. \u2013 NASDAQ:DTIL", "summary": "This article focuses on the enterprise value to EBITDA forward for Precision BioSciences, Inc. (NASDAQ: DTIL). It presents this financial metric within the context of the company's profile on TradingView, indicating that specific value and change data is available. The rest of th", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T06:39:52", "published_display": "04 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Updates Investors with Latest Corporate Deck in July 2026 SEC 8-K Filing", "summary": "Precision BioSciences (NASDAQ: DTIL) filed an 8-K with the SEC in July 2026, releasing an updated corporate deck and detailing significant clinical advancements. Key updates include positive liver biopsy data from its PBGENE-HBV program for chronic hepatitis B, showing direct eli", "url": "https://www.minichart.com.sg/2026/07/01/precision-biosciences-updates-investors-with-latest-corporate-deck-in-july-2026-sec-8-k-filing/", "source_name": "Minichart", "published_at": "2026-07-01T13:10:32", "published_display": "01 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (NASDAQ: DTIL) shares HBV data, DMD trial timeline", "summary": "Precision BioSciences (NASDAQ: DTIL) has furnished an updated corporate deck detailing progress in its gene-editing programs. The company reported liver biopsy data for its PBGENE-HBV chronic hepatitis B treatment, showing a 1-log reduction in cccDNA-derived transcripts, with the", "url": "https://www.stocktitan.net/sec-filings/DTIL/8-k-precision-biosciences-inc-reports-material-event-f38a0d48a8d0.html", "source_name": "Stock Titan", "published_at": "2026-07-01T11:10:32", "published_display": "01 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Joins Russell 2000 Index", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/precision-biosciences-joins-russell-2000-184454884.html", "source_name": "MT Newswires", "published_at": "2026-06-29T18:44:54+00:00", "published_display": "29 Jun 2026 18:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Index", "summary": "Precision BioSciences, Inc. (NasdaqCM: DTIL), a clinical-stage gene editing company, has been added to the Russell 2000 Index. The company utilizes its proprietary ARCUS genome editing platform to develop in vivo gene editing therapies for various genetic and infectious diseases,", "url": "https://www.marketscreener.com/news/precision-biosciences-inc-nasdaqcm-dtil-added-to-russell-2000-index-ce7f5fdfda8cf223", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T18:39:56", "published_display": "29 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Value Benchmark", "summary": "Precision BioSciences, Inc. (NasdaqCM: DTIL), a clinical-stage gene editing company, has been added to the Russell 2000 Value Benchmark. This inclusion follows news that the company was also added to the broader Russell 2000 Index. Precision BioSciences utilizes its proprietary A", "url": "https://www.marketscreener.com/news/precision-biosciences-inc-nasdaqcm-dtil-added-to-russell-2000-value-benchmark-ce7f5fdfd88af424", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T15:39:56", "published_display": "29 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences added to Russell 2000 index By Investing.com", "summary": "Precision BioSciences Inc. (NASDAQ:DTIL) has been added to the Russell 2000 Index, effective at the close of U.S. equity markets on Friday, June 26, 2026. This inclusion is expected to increase the company's visibility with institutional investors, especially as it advances two c", "url": "https://ng.investing.com/news/stock-market-news/precision-biosciences-added-to-russell-2000-index-93CH-2577660", "source_name": "Investing.com Nigeria", "published_at": "2026-06-29T12:09:29", "published_display": "29 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc.(NasdaqCM:DTIL) added to Russell Small Cap Comp Value Benchmark", "summary": "Precision BioSciences, Inc. (NasdaqCM:DTIL), a clinical-stage gene editing company, has been added to the Russell Small Cap Comp Value Benchmark. The company utilizes its proprietary ARCUS genome editing platform to develop therapies for genetic and infectious diseases, with a le", "url": "https://www.marketscreener.com/news/precision-biosciences-inc-nasdaqcm-dtil-added-to-russell-small-cap-comp-value-benchmark-ce7f5fdfd08dfe23", "source_name": "marketscreener.com", "published_at": "2026-06-29T12:09:29", "published_display": "29 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Joins Russell 2000 Index, Highlighting Growth Potential", "summary": "Precision BioSciences (DTIL) is set to join the Russell 2000 Index, a move expected to boost its visibility among institutional investors. The company is advancing clinical initiatives for chronic hepatitis B and Duchenne muscular dystrophy. Despite this milestone and moderate fi", "url": "https://www.gurufocus.com/news/8935955/precision-biosciences-dtil-joins-russell-2000-index-highlighting-growth-potential", "source_name": "GuruFocus", "published_at": "2026-06-29T11:39:56", "published_display": "29 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Announces Inclusion in the Russell 2000\u00ae Index Expanding Market Visibility with Institutional Investors", "summary": "Precision BioSciences, a clinical stage gene editing company, announced its inclusion in the Russell 2000\u00ae Index, effective June 26, 2026. This addition is expected to increase market visibility with institutional investors, coming at a critical time as the company advances two c", "url": "https://www.businesswire.com/news/home/20260629704963/en/Precision-BioSciences-Announces-Inclusion-in-the-Russell-2000-Index-Expanding-Market-Visibility-with-Institutional-Investors", "source_name": "Business Wire", "published_at": "2026-06-29T10:39:56", "published_display": "29 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences enters Russell 2000, lifting visibility with investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNT2pnWkcwUHFPN2JldkNiaVVDRGtfUmdjSzNDTmFZeTAyWjBabElfdjlwNHhweGEyaHZOM1JING5CVjFjVVVYREZzMVFxNnFmT2hlMm1yUXROOHRoTXBFUk4zRlpBemVkN055dzJhM3B2c29QWTJTb25GNTYyQnFjMVhUTndpY25HUDhGUHJPTVRhMHVOZDNIVkRzT05WWWNIQkFTNVktQzJoOWVETmdxY2Vva3pFZ3F2OGhsbmJUcHM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 3000 Value Benchmark", "summary": "Precision BioSciences, Inc. (NasdaqCM: DTIL) has been added to the Russell 3000 Value Benchmark, according to an announcement published on June 28, 2026. This inclusion follows several other recent additions to Russell indices, including the Russell 2000 Index and Russell 2500 In", "url": "https://www.marketscreener.com/news/precision-biosciences-inc-nasdaqcm-dtil-added-to-russell-3000-value-benchmark-ce7f5fdcd08cf425", "source_name": "www.marketscreener.com", "published_at": "2026-06-28T23:10:32", "published_display": "28 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc. Actuals & Estimates (DUS:PBS0)", "summary": "This article provides financial actuals and estimates for Precision BioSciences, Inc. (PBS0) traded on the Dusseldorf Stock Exchange. It includes analyst price forecasts, historical stock prices, earnings reports, revenue figures, net income, and other financial metrics like EBIT", "url": "https://www.tradingview.com/symbols/DUS-PBS0/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T04:10:10", "published_display": "27 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Precision BioSciences, Inc. \u2013 NASDAQ:DTIL", "summary": "The article provides a simple statement about the \"Price to sales forward\" for Precision BioSciences, Inc. (NASDAQ: DTIL) as listed on TradingView. It appears to be an entry from a financial data platform, showing basic company and market information rather than an analytical pie", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T11:41:58", "published_display": "26 Jun 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc. Actuals & Estimates (NASDAQ:DTIL)", "summary": "This article provides a financial overview and analyst estimates for Precision BioSciences, Inc. (NASDAQ: DTIL). It covers the company's stock performance, market capitalization, volatility, and upcoming earnings report. The piece also includes answers to frequently asked questio", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:10:10", "published_display": "26 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Precision BioSciences, Inc. \u2013 NASDAQ:DTIL", "summary": "This article displays financial information for Precision BioSciences, Inc. (NASDAQ: DTIL), specifically focusing on its forward price-to-earnings ratio. It is presented in a format that appears to be a stub or a data point from a financial platform like TradingView, with no addi", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:40", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Precision BioSciences, Inc. \u2013 LS:A400AS", "summary": "This article provides financial information for Precision BioSciences, Inc. (A400AS) on the Lang & Schwarz Tradecenter. It specifically highlights the company's enterprise value to EBIT forward, presenting a quick snapshot of this financial metric. The content indicates the marke", "url": "https://www.tradingview.com/symbols/LS-A400AS/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T00:40:40", "published_display": "26 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences earnings calendar and gene-editing focus, shares remain a small-cap biotech pl", "summary": "Precision BioSciences (DTIL) is a clinical-stage gene-editing company listed on Nasdaq, preparing for its next quarterly earnings update. The company focuses on its Arcus platform and in vivo gene-editing pipeline, with sufficient cash to fund operations into 2027. Analysts view ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/precision-biosciences-earnings-calendar-and-gene-editing-focus-shares/69627263", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-25T19:40:01", "published_display": "25 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) AGM 2026 Summary", "summary": "Precision BioSciences (DTIL) held its 2026 AGM on May 21, 2026, where the company highlighted significant progress in its lead programs, including encouraging Phase I data from the ELIMINATE-B trial for chronic hepatitis B. The company's financial position was strengthened by a $", "url": "https://quartr.com/events/precision-biosciences-dtil-agm-2026_FPmvySpU", "source_name": "Quartr", "published_at": "2026-06-19T18:39:24", "published_display": "19 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Inc (DTIL) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE5FM1ZDQkdHOEF2MTZLdkxlM0xMQ0hLcEVwUEZnSDZYWlFxMmc3dU5KODhmMUluRGFFemE3U2UwQnNpX180ZjdhODNCX2gwQ3l6a0FBN0taQ0luZ1g2TjNJVnREVjdUaEthSzVCN2VQQVFRdmhGa2Jn?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T22:49:20+00:00", "published_display": "17 Jun 2026 22:49", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Inc (DTIL) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Precision BioSciences Inc (DTIL), highlighting major shareholders and institutional holdings. It lists top individual shareholders by proportion and categorizes shareholder types, showing investment advisors and hedge funds as sig", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-dtil/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T12:09:58", "published_display": "17 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Inc (DTIL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Precision BioSciences Inc (DTIL) regarding its dividend history and stock splits. It states that no dividends have been distributed by the company over the past five years. However, it lists multiple instances of a 30-to-1 merger-related stock", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-dtil/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T12:09:57", "published_display": "17 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (NASDAQ: DTIL) amends loan and extends term to 2029", "summary": "Precision BioSciences, Inc. has amended its Loan and Security Agreement with Banc of California, extending the maturity date of its Term Loan from June 30, 2027, to December 31, 2029. This amendment provides the company with over additional two years to repay the loan under the e", "url": "https://www.stocktitan.net/sec-filings/DTIL/8-k-precision-biosciences-inc-reports-material-event-070cf2caab17.html", "source_name": "Stock Titan", "published_at": "2026-06-16T20:09:24", "published_display": "16 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oppenheimer Initiates Precision BioSciences at Outperform", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/oppenheimer-initiates-precision-biosciences-outperform-111010872.html", "source_name": "MT Newswires", "published_at": "2026-06-09T11:10:10+00:00", "published_display": "09 Jun 2026 11:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences stock jumps on hepatitis B trial data", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOMmRtSG9aR2FZYThPMjlrQVZyWHVCaTNub2l4cjAwakhGLXBtcUp6akY4dlN3d0tXWEc2RUM2dmsyS2Ezdlp2UVlfb2MyZm9PUk15bUkxMEtvMHU0NmhUbkt1YzdZdWUtemJoSktFS05oTFA3R3d3MHZDVWJqR2lmdm4xVm96Z1NRZEF1SmlDQ3dYaWo2dXpCQ3RnU3VVeXpBOHBUbll0QlpEYml3d1p5elZGeFZxcHc3MmVmd3FR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywJBVV95cUxQYUJxaENKekVURWpVblBaNzhLOGxXTTFSZ2JLU0NNb093cDd5Q2t5SlotWVQ0RlNBTnBLRTBFd1R6dFJ2Q0NGb2FkRjdGWEFtUUJ2ZzNrazBsakJseEswdk9KNkhxTFRzclhOaVItQmpSaG5oS0xWRTBycTFaWGhwZ2E4bVd6ejRoNHVMclZNRDY2X0NVYVgyT2Rnb3hqdG9vVnZGbmtUYUowMHJxRC1SbFBDMWpDbXAxNk00MnV1aHMwN2lZQUxZOURFeWlxVVpXemZUWXNzRzJDekFUTktQSVBTMFVOOU9YYTlJMnlydzdpMjUtMGIyVmFxc01wZGhZazhLXzE4SmFvZXRKM0FFZGs3dV9QNlZfVWN0aTVwREhRV2Z1MXYxV0tPdk1oTkVxX1owalpTNXZodjZpZDE0UDQ4eXVGaUFsMVZF?oc=5", "source_name": "Business Wire", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOOTdmdGl3ZTNnTE9DdTNfRmdtdXZVLUZrV1JCU2VlZFg5Z01QTGtlMDRuSm94VU10QUlDWlgxcnRrUklBbU9tQlhfUzFKbEZycy1heVlheTBWM25mOGR6US1hRW8wYktFRWhpWkg3ZkJBTWp1NzZRRm9uZmRLSElpTVlJcWFTaFU3cmVFVFlMNVhkUFRlXzRLRFhLMDZzUS0wbElxS0pvNmFRdEhFUmUtdTF5QQ?oc=5", "source_name": "Benzinga", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gene editing for hepatitis B: Precision BioSciences to share new data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOSzROUkpPWjRtdmRXc0duUkk2cUxsa0dKOXNzSDdDTFQ5MmtRREdxb0VTd05FZjBCUjJNYUJIa2o5YkNhczA5VEp2V2VMbXZwZk1OUVp2bU52T19qSzh4SFVYQ2NTMGdKdzhYZlhsX05lNFpORVg3RDk2T3lTVER6SmF3bHJKMnh5b2ZIcG9WeE5vWVJYdVBkYzRYYXl3YS1mUnQ1TlVwanNsX19yTEJqa1kxWEM4R282ZEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygJBVV95cUxQLUxZZmI3RWh5X29DUjE2UUhVdzlMYVYxWWlXUjFjT0ZiYWlfRW4weVFVb0N6ZmRIclN2Q041VkRicFluOFdDSU9kMjNqYlQtMkNxaGxFOWM5Qk5EM1p3R09XWU9nRnZoYTh1bkZkci1CR0JXS2ZZLTZJRWxmQmhqTzR3UkQ5VWVDdHdvdG53ME8yazBZMGtJaVZpSkpEX0tfLUFDamNETDdnbGNkSXg0aUpidEl2aVdvbDgxSzg2LUxxNzgwX3k1UkF5VDhHR3Nqbm1neFV0MlM0UTU5cUZtOHpWS2YxemcxTDlfaFUxbXZpT0V0c0RpZ2tmcW4zWUt3RElKTVp2bEVUUkVCTkZWV2FwNmVxM05wa1VVVnl4WjU3OVdUZkZJWUhTVWZYc0lPMF9za291WXVxNkNCU0tuTjR4Y3k1YVR3Y2c?oc=5", "source_name": "Business Wire", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Bullish: Analysts Just Made A Notable Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOcVdSMFd5cFhpUFJmOWhJVDM4bEUyZmE5Rkt6SlhsWk9PbmFWRWlVRVpnUEM0d1k0WXdwaVR6NVlvQi03Nm9ickd4bmxsY1RKM0tpcU1tYnpMalpicG82ZDNiNnJidzkwcWlnLXZ0aDZVX1FxRWxRMkFOdE0wT3ItZVhYVThYSW8?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analyst Forecasts For Precision BioSciences, Inc. (NASDAQ:DTIL) Are Surging Higher", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/precision-biosciences-dtil-reports-q1-122504482.html", "source_name": "Zacks", "published_at": "2026-05-05T12:25:04+00:00", "published_display": "05 May 2026 12:25", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/precision-biosciences-q1-earnings-snapshot-110932581.html", "source_name": "Associated Press", "published_at": "2026-05-05T11:09:32+00:00", "published_display": "05 May 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQMW1YS2Z5cFRGT1JDLThJc3IwV1pCVURxT0VKRlhyclBxTjZXdzVRam92U3dZZmF3WVZIWVpXbzJ3WktCdG41OXVHN2lXSnotOVFCZmdmdG0xTk5yOTNud1VWWWNmTlczOXpxcE5velI1bDVsdlhsanV0Q0ZQYmxheEU0eWxrekNRSFZQX2VBOGs0R1FjQ3oyTDZjbmZHRGtLaTFpRHg3TjgzTnRNZlFGeEJCbnFwY3ItU1oxU25zQkN3RGstTGtDSjlySU1xeENDVG5xV0pxMGpUMEp0TjdJMXcxbktqU2s?oc=5", "source_name": "Business Wire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgJBVV95cUxQMHUtZUR0NW9acE95NlpCVHR4WlI3dVhRTGlYOHZOdzZIRWF2Y1VEYmZKcHgxVHZnemhiRHpTZC1XdFhWSEVmMEFqbjFESnNFanNkNmFVN3pPOFdRVm8zNENrZEFOYkJtU2xTUlJjdUs2MHhPWUZKNnc4d1NYY3lYU3M4V3pKWUNXXzN5TElKdmk3NzNwS3VTSWNLSGtNdURjRjJvcTFqeC1jdUZaYkRiLTJvcFM0eUVtYUdCQk5fOWotdWxScGVDTHVEU25ycnVjdi1KSG5CdXNLSWJpT0dudXlmbjBxLWJ2c0d3dlBwSnJUaERSX0tyeGlTSjZFTERKZmhaTlZPNUl5emJkRHZmYXY2MTVaRThKS2RBS3U1ZEo2cl9YZVg3Z2Vn?oc=5", "source_name": "Business Wire", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwJBVV95cUxOYmJYelU1ekhoMHc3eTUwVjFrMjZ5cUEtOXYyRnJJOUZFOFAydHc2TDlfR2dxcEhzang1QWFEanZhS3l0QnVrOWt2Y3BHY1pmV2ZSVVU5SjA0MERLb2JsVVVkT2ZfcmY2cWE5czlPbHFTNEpXY3BFWGR6YXhPNXZDZTJ0dnJ4OTg2U0ZpZmdqbnN2blJNQzNmTHNSLWljMjRTb2hWN21oQWR1UXhXbFZhd1hHdUREMVVUeWh2LTRZX1J0MklGam5ucHUwQnJnazE3UUlTYmlUVFhpYnJxeXJTNzhqV3psZjJsd2RDU3ZGOUpWNkZ1VFg0VThodFRsVEo5LW5fcWlNZw?oc=5", "source_name": "Business Wire", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy Precision BioSciences (DTIL) After Golden Cross?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNOGdudU1aaU93M3hrTUl3Q3REME5zZTg2aVd3OHMxRnBCOF9rcklqRXk5VnBMd3E0U0VKT3ZITklTaTVQSE9DM21FUG5sS0VTOFVoUWg5XzRfcTh4WE4xckdoM0d3Y1R4OHNBQTVCUnUyX1k2b2c5WmZ3T21VTE1sUk91OFJiV0E2LTFvaWJ4ZkVjRUNyN2M1YlFLeFk4ZkU4WG52YQ?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-14T07:00:00+00:00", "published_display": "14 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Trading the Move, Not the Narrative: (DTIL) Edition", "summary": "This article analyzes Precision Biosciences Inc. (NASDAQ: DTIL), highlighting weak near-term sentiment with a mid-channel oscillation pattern. It identifies an exceptional 62.0:1 risk-reward short setup and provides institutional trading strategies for different risk profiles. Th", "url": "https://news.stocktradersdaily.com/news_release/14/Trading_the_Move,_Not_the_Narrative:_DTIL_Edition_071526073401_1784115241.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-15T07:34:00", "published_display": "15 Jul 2026 07:34", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Proxy filing Summary", "summary": "Precision BioSciences (DTIL) will hold its annual meeting virtually on May 21, 2026, where shareholders will vote on critical proposals including the election of two Class I directors, auditor ratification, executive compensation, amendments to the 2019 Incentive Award Plan, offi", "url": "https://quartr.com/events/precision-biosciences-dtil-proxy-filing_FPmvy8rw", "source_name": "Quartr", "published_at": "2026-07-13T03:41:16", "published_display": "13 Jul 2026 03:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Short Interest & Short Float | Updated Jul 2026 $DTIL", "summary": "As of June 30, 2026, Precision BioSciences (DTIL) had 2.30 million shares sold short, representing 9.15% of its public float, marking an 18.16% increase from the prior report. The short interest ratio is 3.5 days to cover, indicating a generally positive sentiment. The article pr", "url": "https://www.marketbeat.com/stocks/NASDAQ/DTIL/short-interest/", "source_name": "MarketBeat", "published_at": "2026-07-11T03:33:44", "published_display": "11 Jul 2026 03:33", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Grants Stock Units to New Employees Amid G", "summary": "Precision BioSciences (DTIL) has granted 114,622 restricted stock units to three new employees to attract and retain talent in the competitive biotechnology sector. The company's stock is significantly overvalued according to GuruFocus's GF Value\u2122 of $1.83 compared to its current", "url": "https://www.gurufocus.com/news/8953513/precision-biosciences-grants-stock-units-to-new-employees-amid-growth?mobile=true%3Fmobile%3Dtrue", "source_name": "GuruFocus", "published_at": "2026-07-10T16:39:03", "published_display": "10 Jul 2026 16:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Grants Stock Units to New Employees Amid Growth", "summary": "Precision BioSciences (DTIL) recently granted 114,622 restricted stock units to three new employees as an incentive to attract and retain talent in the competitive biotechnology sector. While this move aims to align employee and shareholder interests, GuruFocus suggests the stock", "url": "https://www.gurufocus.com/news/8953513/precision-biosciences-grants-stock-units-to-new-employees-amid-growth", "source_name": "GuruFocus", "published_at": "2026-07-10T14:06:51", "published_display": "10 Jul 2026 14:06", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Grants Inducement Awards to New Hir", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdjEtdFdRRXhLTXFoWHpCSFdMc0pFQ3BhN1F4SzZPVUhRZnNKX09EbjBKV3dUcVQwaklLekg2dl9ja2VvYklJYkF4VXk0bzRhRmZtNlJPOWZyMkQ1SE1qZmlvSDlTYUR6NVRPejloOS1xQk4xRHd5aVQ3NFhxRHVLWEswRjNWVVVGbnItQzZ0ME1DQmZRYnRNSU9jSkpjQTRFS0d6LXNR?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T11:35:14+00:00", "published_display": "10 Jul 2026 11:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - July 10, 2026", "summary": "Precision BioSciences, Inc. announced the grant of inducement awards consisting of 114,622 restricted stock units (RSUs) to three new employees. These awards were approved by the Compensation Committee and granted under Nasdaq Listing Rule 5635(c)(4) to incentivize their employme", "url": "https://www.biospace.com/press-releases/precision-biosciences-announces-grant-of-inducement-awards-under-nasdaq-listing-rule-5635c4-july-10-2026", "source_name": "BioSpace", "published_at": "2026-07-10T12:10:51", "published_display": "10 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxNdDlmSGRZQUZwTWxrVkJUd20yS2F3NjE3UHFLV1dLRk8tc0doSk9QeWxIUHdBYjFFX09zNFBlNmp1UHNGNTRfQkdIcHM1MTFrTGoxc2pmNG0zVUdnc1dMc3RkRmJ2NWZYdGtyODFTU1Q0cG03cEtHWjhBQWx1UzFPTU94RjVZaG1ZRlB1OUdKb3RZTEMtUTdXdGRoSk9ZeE1kYlVpejRwbk95WFBVR3g4ZmxlOGdGVm55VXBFazJYRnN6VEl5QTRVY3EtOWNOOV9hNTZCcWZzcF9Wekt0WlJyY3lR?oc=5", "source_name": "Business Wire", "published_at": "2026-07-10T11:01:00+00:00", "published_display": "10 Jul 2026 11:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New hires at Precision BioSciences receive 114,622 restricted stock units", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNcVZhYS1PekZPSEtOXzlmeDlTZFh6WklrTGhLSDNtbDRtQkx1N3l1OFR5NnJaZmNuNTNvbno4OEFRaUZUbk9RcEhISjhpaWRiTDJ5bzVJODd2NzRUdWZvOE00cFIzUHJvNkZLaC1MQTFONm9qYWlzcXRoLTBNcDU4UW5CRm5hVjhOY1Y2ek16YnZ6WUo4VTVxRC1mQXd5S3FwYkxEUXBoT2tkbXg1V2djUW40dzFfRVhpLUQyYQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T11:01:00+00:00", "published_display": "10 Jul 2026 11:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Grants Inducement Awards to New Hires", "summary": "Precision BioSciences (DTIL) has granted inducement awards, totaling 114,622 restricted stock units, to three new employees to attract and retain talent in the competitive biotechnology sector. Despite this strategic move, the company faces challenges including a declining revenu", "url": "https://www.gurufocus.com/news/8953278/precision-biosciences-dtil-grants-inducement-awards-to-new-hires", "source_name": "GuruFocus", "published_at": "2026-07-10T11:10:51", "published_display": "10 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $60", "summary": "H.C. Wainwright has reiterated its Buy rating for Precision BioSciences (DTIL.US) and maintained a target price of $60. This reflects the firm's continued positive outlook on the company's prospects.", "url": "https://www.moomoo.com/news/post/72710793/hc-wainwright-maintains-precision-biosciences-dtilus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-10T03:10:39", "published_display": "10 Jul 2026 03:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc. Actuals & Estimates (TRADEGATE:PBS0)", "summary": "This article provides financial actuals and estimates for Precision BioSciences, Inc. (PBS0) traded on the TRADEGATE exchange. It covers analyst forecasts, historical stock prices, upcoming earnings dates, and recent financial performance including earnings per share, revenue, an", "url": "https://www.tradingview.com/symbols/TRADEGATE-PBS0/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-07-10T00:10:51", "published_display": "10 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQTDUtdnREV2FLd2pUZGFJWVBsT1FoLXVUZmFuMHA2OFJESTUyRGtpVEpVd0ZDbGUxVzlWaVhjTUpZMUxpeVJ5Ql9XUS1iTHZPWEl0bDZDMUlWMWhnWlZIdDJUQ2ZULUNQZ24xVHVPQVRRdXNiRFFkU2dRLXV1ZUxHc293VjZfbS1Kc2dGVGlGbmdtUjVRSUFWWTRlV285M2ZYV3BrUlVKM2Y?oc=5", "source_name": "Market source", "published_at": "2026-07-08T14:32:00+00:00", "published_display": "08 Jul 2026 14:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Precision BioSciences, Inc. \u2013 NASDAQ:DTIL", "summary": "This article displays financial information for Precision BioSciences, Inc. (NASDAQ: DTIL) regarding its enterprise value to revenue forward. The content is presented within the TradingView platform, noting that the market is closed and no trades have occurred for the stock.", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T12:39:34", "published_display": "06 Jul 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Precision BioSciences, Inc. \u2013 NASDAQ:DTIL", "summary": "This article focuses on the enterprise value to EBITDA forward for Precision BioSciences, Inc. (NASDAQ: DTIL). It presents this financial metric within the context of the company's profile on TradingView, indicating that specific value and change data is available. The rest of th", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T06:39:52", "published_display": "04 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Updates Investors with Latest Corporate Deck in July 2026 SEC 8-K Filing", "summary": "Precision BioSciences (NASDAQ: DTIL) filed an 8-K with the SEC in July 2026, releasing an updated corporate deck and detailing significant clinical advancements. Key updates include positive liver biopsy data from its PBGENE-HBV program for chronic hepatitis B, showing direct eli", "url": "https://www.minichart.com.sg/2026/07/01/precision-biosciences-updates-investors-with-latest-corporate-deck-in-july-2026-sec-8-k-filing/", "source_name": "Minichart", "published_at": "2026-07-01T13:10:32", "published_display": "01 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (NASDAQ: DTIL) shares HBV data, DMD trial timeline", "summary": "Precision BioSciences (NASDAQ: DTIL) has furnished an updated corporate deck detailing progress in its gene-editing programs. The company reported liver biopsy data for its PBGENE-HBV chronic hepatitis B treatment, showing a 1-log reduction in cccDNA-derived transcripts, with the", "url": "https://www.stocktitan.net/sec-filings/DTIL/8-k-precision-biosciences-inc-reports-material-event-f38a0d48a8d0.html", "source_name": "Stock Titan", "published_at": "2026-07-01T11:10:32", "published_display": "01 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Joins Russell 2000 Index", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/precision-biosciences-joins-russell-2000-184454884.html", "source_name": "MT Newswires", "published_at": "2026-06-29T18:44:54+00:00", "published_display": "29 Jun 2026 18:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Index", "summary": "Precision BioSciences, Inc. (NasdaqCM: DTIL), a clinical-stage gene editing company, has been added to the Russell 2000 Index. The company utilizes its proprietary ARCUS genome editing platform to develop in vivo gene editing therapies for various genetic and infectious diseases,", "url": "https://www.marketscreener.com/news/precision-biosciences-inc-nasdaqcm-dtil-added-to-russell-2000-index-ce7f5fdfda8cf223", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T18:39:56", "published_display": "29 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Value Benchmark", "summary": "Precision BioSciences, Inc. (NasdaqCM: DTIL), a clinical-stage gene editing company, has been added to the Russell 2000 Value Benchmark. This inclusion follows news that the company was also added to the broader Russell 2000 Index. Precision BioSciences utilizes its proprietary A", "url": "https://www.marketscreener.com/news/precision-biosciences-inc-nasdaqcm-dtil-added-to-russell-2000-value-benchmark-ce7f5fdfd88af424", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T15:39:56", "published_display": "29 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences added to Russell 2000 index By Investing.com", "summary": "Precision BioSciences Inc. (NASDAQ:DTIL) has been added to the Russell 2000 Index, effective at the close of U.S. equity markets on Friday, June 26, 2026. This inclusion is expected to increase the company's visibility with institutional investors, especially as it advances two c", "url": "https://ng.investing.com/news/stock-market-news/precision-biosciences-added-to-russell-2000-index-93CH-2577660", "source_name": "Investing.com Nigeria", "published_at": "2026-06-29T12:09:29", "published_display": "29 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc.(NasdaqCM:DTIL) added to Russell Small Cap Comp Value Benchmark", "summary": "Precision BioSciences, Inc. (NasdaqCM:DTIL), a clinical-stage gene editing company, has been added to the Russell Small Cap Comp Value Benchmark. The company utilizes its proprietary ARCUS genome editing platform to develop therapies for genetic and infectious diseases, with a le", "url": "https://www.marketscreener.com/news/precision-biosciences-inc-nasdaqcm-dtil-added-to-russell-small-cap-comp-value-benchmark-ce7f5fdfd08dfe23", "source_name": "marketscreener.com", "published_at": "2026-06-29T12:09:29", "published_display": "29 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Joins Russell 2000 Index, Highlighting Growth Potential", "summary": "Precision BioSciences (DTIL) is set to join the Russell 2000 Index, a move expected to boost its visibility among institutional investors. The company is advancing clinical initiatives for chronic hepatitis B and Duchenne muscular dystrophy. Despite this milestone and moderate fi", "url": "https://www.gurufocus.com/news/8935955/precision-biosciences-dtil-joins-russell-2000-index-highlighting-growth-potential", "source_name": "GuruFocus", "published_at": "2026-06-29T11:39:56", "published_display": "29 Jun 2026 11:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Announces Inclusion in the Russell 2000\u00ae Index Expanding Market Visibility with Institutional Investors", "summary": "Precision BioSciences, a clinical stage gene editing company, announced its inclusion in the Russell 2000\u00ae Index, effective June 26, 2026. This addition is expected to increase market visibility with institutional investors, coming at a critical time as the company advances two c", "url": "https://www.businesswire.com/news/home/20260629704963/en/Precision-BioSciences-Announces-Inclusion-in-the-Russell-2000-Index-Expanding-Market-Visibility-with-Institutional-Investors", "source_name": "Business Wire", "published_at": "2026-06-29T10:39:56", "published_display": "29 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences enters Russell 2000, lifting visibility with investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNT2pnWkcwUHFPN2JldkNiaVVDRGtfUmdjSzNDTmFZeTAyWjBabElfdjlwNHhweGEyaHZOM1JING5CVjFjVVVYREZzMVFxNnFmT2hlMm1yUXROOHRoTXBFUk4zRlpBemVkN055dzJhM3B2c29QWTJTb25GNTYyQnFjMVhUTndpY25HUDhGUHJPTVRhMHVOZDNIVkRzT05WWWNIQkFTNVktQzJoOWVETmdxY2Vva3pFZ3F2OGhsbmJUcHM?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 3000 Value Benchmark", "summary": "Precision BioSciences, Inc. (NasdaqCM: DTIL) has been added to the Russell 3000 Value Benchmark, according to an announcement published on June 28, 2026. This inclusion follows several other recent additions to Russell indices, including the Russell 2000 Index and Russell 2500 In", "url": "https://www.marketscreener.com/news/precision-biosciences-inc-nasdaqcm-dtil-added-to-russell-3000-value-benchmark-ce7f5fdcd08cf425", "source_name": "www.marketscreener.com", "published_at": "2026-06-28T23:10:32", "published_display": "28 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc. Actuals & Estimates (DUS:PBS0)", "summary": "This article provides financial actuals and estimates for Precision BioSciences, Inc. (PBS0) traded on the Dusseldorf Stock Exchange. It includes analyst price forecasts, historical stock prices, earnings reports, revenue figures, net income, and other financial metrics like EBIT", "url": "https://www.tradingview.com/symbols/DUS-PBS0/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T04:10:10", "published_display": "27 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Precision BioSciences, Inc. \u2013 NASDAQ:DTIL", "summary": "The article provides a simple statement about the \"Price to sales forward\" for Precision BioSciences, Inc. (NASDAQ: DTIL) as listed on TradingView. It appears to be an entry from a financial data platform, showing basic company and market information rather than an analytical pie", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T11:41:58", "published_display": "26 Jun 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences, Inc. Actuals & Estimates (NASDAQ:DTIL)", "summary": "This article provides a financial overview and analyst estimates for Precision BioSciences, Inc. (NASDAQ: DTIL). It covers the company's stock performance, market capitalization, volatility, and upcoming earnings report. The piece also includes answers to frequently asked questio", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:10:10", "published_display": "26 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Precision BioSciences, Inc. \u2013 NASDAQ:DTIL", "summary": "This article displays financial information for Precision BioSciences, Inc. (NASDAQ: DTIL), specifically focusing on its forward price-to-earnings ratio. It is presented in a format that appears to be a stub or a data point from a financial platform like TradingView, with no addi", "url": "https://www.tradingview.com/symbols/NASDAQ-DTIL/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:40", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Precision BioSciences, Inc. \u2013 LS:A400AS", "summary": "This article provides financial information for Precision BioSciences, Inc. (A400AS) on the Lang & Schwarz Tradecenter. It specifically highlights the company's enterprise value to EBIT forward, presenting a quick snapshot of this financial metric. The content indicates the marke", "url": "https://www.tradingview.com/symbols/LS-A400AS/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T00:40:40", "published_display": "26 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences earnings calendar and gene-editing focus, shares remain a small-cap biotech pl", "summary": "Precision BioSciences (DTIL) is a clinical-stage gene-editing company listed on Nasdaq, preparing for its next quarterly earnings update. The company focuses on its Arcus platform and in vivo gene-editing pipeline, with sufficient cash to fund operations into 2027. Analysts view ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/precision-biosciences-earnings-calendar-and-gene-editing-focus-shares/69627263", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-25T19:40:01", "published_display": "25 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) AGM 2026 Summary", "summary": "Precision BioSciences (DTIL) held its 2026 AGM on May 21, 2026, where the company highlighted significant progress in its lead programs, including encouraging Phase I data from the ELIMINATE-B trial for chronic hepatitis B. The company's financial position was strengthened by a $", "url": "https://quartr.com/events/precision-biosciences-dtil-agm-2026_FPmvySpU", "source_name": "Quartr", "published_at": "2026-06-19T18:39:24", "published_display": "19 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Inc (DTIL) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE5FM1ZDQkdHOEF2MTZLdkxlM0xMQ0hLcEVwUEZnSDZYWlFxMmc3dU5KODhmMUluRGFFemE3U2UwQnNpX180ZjdhODNCX2gwQ3l6a0FBN0taQ0luZ1g2TjNJVnREVjdUaEthSzVCN2VQQVFRdmhGa2Jn?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T22:49:20+00:00", "published_display": "17 Jun 2026 22:49", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Inc (DTIL) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Precision BioSciences Inc (DTIL), highlighting major shareholders and institutional holdings. It lists top individual shareholders by proportion and categorizes shareholder types, showing investment advisors and hedge funds as sig", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-dtil/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T12:09:58", "published_display": "17 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Inc (DTIL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Precision BioSciences Inc (DTIL) regarding its dividend history and stock splits. It states that no dividends have been distributed by the company over the past five years. However, it lists multiple instances of a 30-to-1 merger-related stock", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-dtil/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T12:09:57", "published_display": "17 Jun 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (NASDAQ: DTIL) amends loan and extends term to 2029", "summary": "Precision BioSciences, Inc. has amended its Loan and Security Agreement with Banc of California, extending the maturity date of its Term Loan from June 30, 2027, to December 31, 2029. This amendment provides the company with over additional two years to repay the loan under the e", "url": "https://www.stocktitan.net/sec-filings/DTIL/8-k-precision-biosciences-inc-reports-material-event-070cf2caab17.html", "source_name": "Stock Titan", "published_at": "2026-06-16T20:09:24", "published_display": "16 Jun 2026 20:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oppenheimer Initiates Precision BioSciences at Outperform", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/oppenheimer-initiates-precision-biosciences-outperform-111010872.html", "source_name": "MT Newswires", "published_at": "2026-06-09T11:10:10+00:00", "published_display": "09 Jun 2026 11:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences stock jumps on hepatitis B trial data", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOMmRtSG9aR2FZYThPMjlrQVZyWHVCaTNub2l4cjAwakhGLXBtcUp6akY4dlN3d0tXWEc2RUM2dmsyS2Ezdlp2UVlfb2MyZm9PUk15bUkxMEtvMHU0NmhUbkt1YzdZdWUtemJoSktFS05oTFA3R3d3MHZDVWJqR2lmdm4xVm96Z1NRZEF1SmlDQ3dYaWo2dXpCQ3RnU3VVeXpBOHBUbll0QlpEYml3d1p5elZGeFZxcHc3MmVmd3FR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywJBVV95cUxQYUJxaENKekVURWpVblBaNzhLOGxXTTFSZ2JLU0NNb093cDd5Q2t5SlotWVQ0RlNBTnBLRTBFd1R6dFJ2Q0NGb2FkRjdGWEFtUUJ2ZzNrazBsakJseEswdk9KNkhxTFRzclhOaVItQmpSaG5oS0xWRTBycTFaWGhwZ2E4bVd6ejRoNHVMclZNRDY2X0NVYVgyT2Rnb3hqdG9vVnZGbmtUYUowMHJxRC1SbFBDMWpDbXAxNk00MnV1aHMwN2lZQUxZOURFeWlxVVpXemZUWXNzRzJDekFUTktQSVBTMFVOOU9YYTlJMnlydzdpMjUtMGIyVmFxc01wZGhZazhLXzE4SmFvZXRKM0FFZGs3dV9QNlZfVWN0aTVwREhRV2Z1MXYxV0tPdk1oTkVxX1owalpTNXZodjZpZDE0UDQ4eXVGaUFsMVZF?oc=5", "source_name": "Business Wire", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Precision BioSciences Stock Gaining Wednesday? - Precision BioSciences (NASDAQ:DTIL)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOOTdmdGl3ZTNnTE9DdTNfRmdtdXZVLUZrV1JCU2VlZFg5Z01QTGtlMDRuSm94VU10QUlDWlgxcnRrUklBbU9tQlhfUzFKbEZycy1heVlheTBWM25mOGR6US1hRW8wYktFRWhpWkg3ZkJBTWp1NzZRRm9uZmRLSElpTVlJcWFTaFU3cmVFVFlMNVhkUFRlXzRLRFhLMDZzUS0wbElxS0pvNmFRdEhFUmUtdTF5QQ?oc=5", "source_name": "Benzinga", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gene editing for hepatitis B: Precision BioSciences to share new data", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOSzROUkpPWjRtdmRXc0duUkk2cUxsa0dKOXNzSDdDTFQ5MmtRREdxb0VTd05FZjBCUjJNYUJIa2o5YkNhczA5VEp2V2VMbXZwZk1OUVp2bU52T19qSzh4SFVYQ2NTMGdKdzhYZlhsX05lNFpORVg3RDk2T3lTVER6SmF3bHJKMnh5b2ZIcG9WeE5vWVJYdVBkYzRYYXl3YS1mUnQ1TlVwanNsX19yTEJqa1kxWEM4R282ZEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygJBVV95cUxQLUxZZmI3RWh5X29DUjE2UUhVdzlMYVYxWWlXUjFjT0ZiYWlfRW4weVFVb0N6ZmRIclN2Q041VkRicFluOFdDSU9kMjNqYlQtMkNxaGxFOWM5Qk5EM1p3R09XWU9nRnZoYTh1bkZkci1CR0JXS2ZZLTZJRWxmQmhqTzR3UkQ5VWVDdHdvdG53ME8yazBZMGtJaVZpSkpEX0tfLUFDamNETDdnbGNkSXg0aUpidEl2aVdvbDgxSzg2LUxxNzgwX3k1UkF5VDhHR3Nqbm1neFV0MlM0UTU5cUZtOHpWS2YxemcxTDlfaFUxbXZpT0V0c0RpZ2tmcW4zWUt3RElKTVp2bEVUUkVCTkZWV2FwNmVxM05wa1VVVnl4WjU3OVdUZkZJWUhTVWZYc0lPMF9za291WXVxNkNCU0tuTjR4Y3k1YVR3Y2c?oc=5", "source_name": "Business Wire", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bullish: Analysts Just Made A Notable Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOcVdSMFd5cFhpUFJmOWhJVDM4bEUyZmE5Rkt6SlhsWk9PbmFWRWlVRVpnUEM0d1k0WXdwaVR6NVlvQi03Nm9ickd4bmxsY1RKM0tpcU1tYnpMalpicG82ZDNiNnJidzkwcWlnLXZ0aDZVX1FxRWxRMkFOdE0wT3ItZVhYVThYSW8?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analyst Forecasts For Precision BioSciences, Inc. (NASDAQ:DTIL) Are Surging Higher", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/precision-biosciences-dtil-reports-q1-122504482.html", "source_name": "Zacks", "published_at": "2026-05-05T12:25:04+00:00", "published_display": "05 May 2026 12:25", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/precision-biosciences-q1-earnings-snapshot-110932581.html", "source_name": "Associated Press", "published_at": "2026-05-05T11:09:32+00:00", "published_display": "05 May 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQMW1YS2Z5cFRGT1JDLThJc3IwV1pCVURxT0VKRlhyclBxTjZXdzVRam92U3dZZmF3WVZIWVpXbzJ3WktCdG41OXVHN2lXSnotOVFCZmdmdG0xTk5yOTNud1VWWWNmTlczOXpxcE5velI1bDVsdlhsanV0Q0ZQYmxheEU0eWxrekNRSFZQX2VBOGs0R1FjQ3oyTDZjbmZHRGtLaTFpRHg3TjgzTnRNZlFGeEJCbnFwY3ItU1oxU25zQkN3RGstTGtDSjlySU1xeENDVG5xV0pxMGpUMEp0TjdJMXcxbktqU2s?oc=5", "source_name": "Business Wire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgJBVV95cUxQMHUtZUR0NW9acE95NlpCVHR4WlI3dVhRTGlYOHZOdzZIRWF2Y1VEYmZKcHgxVHZnemhiRHpTZC1XdFhWSEVmMEFqbjFESnNFanNkNmFVN3pPOFdRVm8zNENrZEFOYkJtU2xTUlJjdUs2MHhPWUZKNnc4d1NYY3lYU3M4V3pKWUNXXzN5TElKdmk3NzNwS3VTSWNLSGtNdURjRjJvcTFqeC1jdUZaYkRiLTJvcFM0eUVtYUdCQk5fOWotdWxScGVDTHVEU25ycnVjdi1KSG5CdXNLSWJpT0dudXlmbjBxLWJ2c0d3dlBwSnJUaERSX0tyeGlTSjZFTERKZmhaTlZPNUl5emJkRHZmYXY2MTVaRThKS2RBS3U1ZEo2cl9YZVg3Z2Vn?oc=5", "source_name": "Business Wire", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwJBVV95cUxOYmJYelU1ekhoMHc3eTUwVjFrMjZ5cUEtOXYyRnJJOUZFOFAydHc2TDlfR2dxcEhzang1QWFEanZhS3l0QnVrOWt2Y3BHY1pmV2ZSVVU5SjA0MERLb2JsVVVkT2ZfcmY2cWE5czlPbHFTNEpXY3BFWGR6YXhPNXZDZTJ0dnJ4OTg2U0ZpZmdqbnN2blJNQzNmTHNSLWljMjRTb2hWN21oQWR1UXhXbFZhd1hHdUREMVVUeWh2LTRZX1J0MklGam5ucHUwQnJnazE3UUlTYmlUVFhpYnJxeXJTNzhqV3psZjJsd2RDU3ZGOUpWNkZ1VFg0VThodFRsVEo5LW5fcWlNZw?oc=5", "source_name": "Business Wire", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy Precision BioSciences (DTIL) After Golden Cross?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNOGdudU1aaU93M3hrTUl3Q3REME5zZTg2aVd3OHMxRnBCOF9rcklqRXk5VnBMd3E0U0VKT3ZITklTaTVQSE9DM21FUG5sS0VTOFVoUWg5XzRfcTh4WE4xckdoM0d3Y1R4OHNBQTVCUnUyX1k2b2c5WmZ3T21VTE1sUk91OFJiV0E2LTFvaWJ4ZkVjRUNyN2M1YlFLeFk4ZkU4WG52YQ?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-14T07:00:00+00:00", "published_display": "14 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 107, "total_relevant": 64, "sentiment_summary": {"positive": 22, "negative": 6, "neutral": 36, "score": 55, "total": 64, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 20.35, "count": 37}, {"event": "earnings", "label": "Earnings", "weight": 10.6, "count": 20}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 22, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 8.76, "latest_week": "2026-07-10", "one_week_move": 7.1, "four_week_move": 43.6, "twelve_week_move": 11.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.348774, "market_dynamics_buy_signal": false, "relative_strength": 34.452896, "fair_value_gap": 8.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 40.4225, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+7.1% over one week, +43.6% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 9}, {"label": "Market source", "count": 8}, {"label": "Business Wire", "count": 7}, {"label": "GuruFocus", "count": 5}, {"label": "Stock Titan", "count": 5}, {"label": "simplywall.st", "count": 4}, {"label": "www.marketscreener.com", "count": 3}, {"label": "TradingKey", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 56}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 37}, {"label": "Earnings", "count": 20}, {"label": "Analyst action", "count": 4}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "56", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+7.1% over one week, +43.6% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Trading the Move, Not the Narrative: (DTIL) Edition"}], "updated_at": "2026-07-16T00:39:14.199455+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}